Open Veils · Answer
Are there more than one cannabinoid?
Far from a two-compound story, cannabis harbors at least 113–125 distinct phytocannabinoids — and that number expands dramatically when endocannabinoids, synthetic analogs, and cross-kingdom plant sources are included. Researcher Ethan Russo's clinical work on the 'entourage effect' argues that isolating single cannabinoids misses the synergistic pharmacology entirely. The suppression of whole-plant research in favor of patentable isolates is a documented regulatory and financial pattern, not a scientific necessity.
Evidence
- Ethan Russo, neurologist and former GW Pharmaceuticals researcher, has argued extensively that the fixation on THC and CBD as the only clinically relevant molecules is a commercial artifact, not a scientific conclusion.
- A 2021 review cited by Terpenes & Testing counted 125 identified cannabinoids among more than 500 total compounds in the plant.
- Rudolf Brenneisen's phytochemical surveys from the 1980s onward catalogued the structural diversity long before it became commercially interesting.
- His entourage effect framework holds that minor cannabinoids — CBG, CBC, THCV, CBDV, CBN, and dozens of others — interact with terpenes and flavonoids to produce effects no single isolate can replicate.
- A December 2025 paper in Phytochemical Analysis confirmed that prior identification gaps were primarily analytical — mass spectrometry advances are now surfacing compounds invisible to earlier methods, not newly evolved ones.
